|Eli Lilly Settles Suit Over Breast Cancer Possibly Linked to Pregnancy Drug|
|Written by Legal Intern|
|Thursday, 10 January 2013 14:47|
Four sisters who filed a lawsuit claiming that their breast cancer was caused by their mother's use of a synthetic estrogen during pregnancy, have reached a settlement with the pharmaceutical company Eli Lilly and Co. According to the Melnick sisters' claim, their mother took DES, or diethylstilbestrol, in the 1950s to reduce the risk of premature birth, miscarriage and other problems during pregnancy, and all four sisters have since developed breast cancer. In the 1970s, DES was taken off the market after being tied to a rare vaginal cancer in women whose mothers took the drug while pregnant. If you or a loved one was exposed to DES or another pharmaceutical drug during pregnancy, and you have since suffered a major side effect like cancer, contact our reputable attorneys at Atkins & Markoff to discuss your legal options.
DES Removed From Market for Link to CancerThe Melnick sisters' case was the first to go to trial out of a host of similar claims filed in Boston and across the United States. Diethylstilbestrol was prescribed to millions of pregnant women over the course of thirty years to prevent adverse events during pregnancy, including miscarriages and premature births. However, in an opening statement during the Melnick trial, a lawyer for the sisters said that Eli Lilly failed to test the effects of the medication on fetuses before promoting it as a method of preventing miscarriages in pregnant women. After DES was linked to vaginal cancer in women exposed to the drug in utero, and subsequently removed from the market, research showed that the medication did not actually prevent miscarriages.
DES Exposure in Pregnancy and Potential Side EffectsAccording to the four Melnick sisters, they all developed breast cancer in their 40s after their mother took DES during pregnancy, and have undergone treatments ranging from lump-removal surgery to radiation, chemotherapy and a full mastectomy. Their mother did not take the drug while pregnant with a fifth sister, however, and that sister has not developed breast cancer. In addition to breast cancer, the sisters have also suffered from fertility problems, miscarriages and other reproductive tract issues long suspected of bring linked to prenatal exposure to DES. For its part, Indianapolis-based Eli Lilly said it still denies that its medication caused the sisters' breast cancer, but noted that a settlement was in its best interest. The settlement, for an undisclosed amount, was reached on January 9, the second day of the Melnick sisters' trial.
Contact Our Experienced Attorneys TodayDiethylstilbestrol was not patented and was made by many different pharmaceutical companies, including Eli Lilly. A total of 51 women have DES lawsuits pending in U.S. District Court in Boston, against more than a dozen drug companies that made or marketed the medication, and thousands of lawsuits have been filed over vaginal and cervical cancer and fertility problems allegedly linked to DES exposure in pregnancy, many of which have been settled. If you have developed a serious medical condition that you believe to be caused by exposure to a pharmaceutical drug like DES during pregnancy, consult our knowledgeable lawyers at Atkins & Markoff today. Our attorneys have extensive experience handling defective drug claims, and will work diligently to help you pursue financial compensation for your injuries, medical bills and other damages.
We Are Here for You
Our attorneys will evaluate your situation for FREE with no obligation. Click SUBMIT or pick up the phone and call us now at